All Releases
 |
Momenta Pharmaceuticals Provides Litigation Update
Aug 26, 2010
|
9.4 KB |
|
| |
CAMBRIDGE, Mass., Aug 26, 2010 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that on August 25, 2010, the United States District Court for the District of Columbia denied sanofi-aventis U.S. LLC's ...
|
|
Momenta Pharmaceuticals to Present at the Canaccord 30th Annual Global Growth Conference and the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference
Aug 9, 2010
|
7.5 KB |
|
| |
CAMBRIDGE, Mass., Aug 9, 2010 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that management will deliver a corporate presentation at two upcoming healthcare conferences: Canaccord 30th Annual Globa...
|
|
Momenta Pharmaceuticals Reports Financial Results for the Second Quarter of 2010
Aug 2, 2010
|
12.9 KB |
|
| |
CAMBRIDGE, Mass., Aug 2, 2010 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today reported its financial results for the quarter ended June 30, 2010.
For the second quarter of 2010, the Company reported a net ...
|
|
Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Second Quarter 2010 Financial Results
Jul 28, 2010
|
7.4 KB |
|
| |
CAMBRIDGE, Mass., Jul 28, 2010 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will report its financial results for the second quarter ended June 30, 2010 before the U.S. financial markets open on Monday, August 2,...
|
|
Momenta Pharmaceuticals Provides Update Regarding Generic Lovenox(R) Litigation
Jul 27, 2010
|
7.5 KB |
|
| |
CAMBRIDGE, Mass., Jul 27, 2010 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today provided an update regarding a lawsuit that Sanofi-Aventis U.S. LLC filed in the United States District Court for the District of ...
|
|
Momenta Pharmaceuticals Announces Conference Call Details Regarding Approval for Generic Lovenox(R)
Jul 23, 2010
|
7.7 KB |
|
| |
CAMBRIDGE, Mass., Jul 23, 2010 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will conduct a conference call to discuss the approval of generic Lovenox.
Management will host a conference...
|
|
Momenta Pharmaceuticals Announces FDA Approval for First Generic Lovenox(R)
Jul 23, 2010
|
9.2 KB |
|
| |
CAMBRIDGE, Mass., Jul 23, 2010 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that the U.S. Food and Drug Administration has granted marketing approval of the Abbreviated New Drug Application (ANDA)...
|
|
Momenta Pharmaceuticals to Present at Goldman Sachs 31st Annual Global Healthcare Conference
Jun 11, 2010
|
7.4 KB |
|
| |
CAMBRIDGE, Mass., Jun 11, 2010 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Richard Shea, Chief Financial Officer, will deliver a corporate presentation at the Goldman Sachs 31st Annual Globa...
|
|
Momenta Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference
Jun 2, 2010
|
7.3 KB |
|
| |
CAMBRIDGE, Mass., Jun 2, 2010 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Richard Shea, Chief Financial Officer, will deliver a corporate presentation at the Jefferies 2010 Global Life Scien...
|
|
Momenta Pharmaceuticals to Present at the 2010 Citi Investment Research Global Healthcare Conference
May 20, 2010
|
7.3 KB |
|
| |
CAMBRIDGE, Mass., May 20, 2010 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Richard P. Shea, Chief Financial Officer, will deliver a corporate presentation at the 2010 Citi Investment Researc...
|
|
Momenta Pharmaceuticals Announces Date for 2010 Annual Meeting of Stockholders
May 20, 2010
|
7.0 KB |
|
| |
CAMBRIDGE, Mass., May 20, 2010 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will hold its Annual Meeting of Stockholders on June 9, 2010 at 10:30 am EDT at the offices of Wilmer Cutler Pic...
|
|
Momenta Pharmaceuticals Reports Financial Results for the First Quarter of 2010
May 6, 2010
|
12.6 KB |
|
| |
CAMBRIDGE, Mass., May 6, 2010 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today reported its financial results for the quarter ended March 31, 2010.
For the first quarter of 2010, the Company reported a net ...
|
|
Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for First Quarter 2010 Financial Results
Apr 28, 2010
|
7.8 KB |
|
| |
CAMBRIDGE, Mass., Apr 28, 2010 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will report its financial results for the first quarter 2010 before the U.S. financial markets open on Thursday, May 6, 2010.
Management w...
|
|
Momenta Pharmaceuticals to Present at Deutsche Bank 35th Annual Healthcare Conference
Apr 28, 2010
|
7.3 KB |
|
| |
CAMBRIDGE, Mass., Apr 28, 2010 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Richard P. Shea, Chief Financial Officer, will deliver a corporate presentation at The Deutsche Bank 35th Annual He...
|
|
Momenta Pharmaceuticals Announces Presentation of Preclinical Data on the Anti-Cancer Properties of M402 at AACR Meeting
Apr 19, 2010
|
10.6 KB |
|
| |
CAMBRIDGE, Mass., Apr 19, 2010 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex mixture drugs, today announced presentation of results from a preclinical study of its novel oncology drug candidate, M402, in a murine pancrea...
|
|
Momenta Pharmaceuticals Announces Presentation of M402 Preclinical Data at Upcoming AACR Meeting
Apr 15, 2010
|
7.3 KB |
|
| |
CAMBRIDGE, Mass., Apr 15, 2010 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex mixture drugs, today announced that preclinical data for its novel drug candidate, M402, will be presented at the 101st Annual Meeting of the A...
|
|
Momenta Pharmaceuticals Announces Publication of the M118 EMINENCE Clinical Trial Results in Circulation
Apr 7, 2010
|
11.7 KB |
|
| |
CAMBRIDGE, Mass., Apr 7, 2010 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex mixture drugs, today announced that the results of the M118 EMINENCE clinical trial have published in Circulation. The paper, entitled Evaluatio...
|
|
Momenta Pharmaceuticals to Present at The Cowen and Company 30th Annual Healthcare Conference
Mar 3, 2010
|
7.0 KB |
|
| |
CAMBRIDGE, Mass., Mar 3, 2010 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Craig Wheeler, Chief Executive Officer, will deliver a corporate presentation at The Cowen and Company 30th Annual H...
|
|
Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year End 2009
Feb 11, 2010
|
14.6 KB |
|
| |
CAMBRIDGE, Mass., Feb 11, 2010 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today reported its financial results for the fourth quarter and year ended December 31, 2009.
For the fourth quarter of 2009 the Com...
|
|
Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Fourth Quarter and Year Ended 2009 Financial Results
Feb 4, 2010
|
7.5 KB |
|
| |
CAMBRIDGE, Mass., Feb 4, 2010 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will report its financial results for the fourth quarter and year ended December 31, 2009 before the U.S. financial markets open on Thurs...
|
|
|
